Endoscopic injection sclerotherapy for esophageal varices in the elderly

Masayuki Ohta, Makoto Hashizume, Tatsuro Kamakura, Kiichiro Ueno, Morimasa Tomikawa, Kazuo Tanoue, Seigo Kitano, Keizo Sugimachi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A group of 1127 patients who underwent sclerotherapy for esophageal varices were compared for outcome in terms of age: over and ander age 70 years. Esophageal varices were completely eradicated in 81 of 110 patients >70 years (73.6%) and in 791 of 1017 patients <70 years (77.8%). Gastrointestinal bleeding after sclerotherapy occurred in 9 patients >70 years (8.2%) and in 84 of those <70 years (8.3%). Complications occurred in 16 patients >70 years (14.5%) and in 141 <70 years (13.9%). Liver failure and hepatoma accounted for more than 80% of the causes of death in both groups (80.3% versus 83.8%). The 5-year cumulative survival rates in patients with bleeding esophageal varices (bleeders) without hepatoma were 21.8% in those >70 years and 58.7% in those <70 years (p<0.01), the relative survivals being 25.3% versus 66.6%. Patients without hepatoma and treated by prophylactic sclerotherapy accounted for 66.2% of patients >70 years and 61.7% of those <70 years, the relative survivals being 75.9% versus 71.9%. As analyzed by the Cox proportional-hazards model, age >70 years was a prognostic factor in the bleeders (p<0.01) but not in the nonbleeders. We recommend that elderly patients with esophageal varices be given prophylactic sclerotherapy, as the outcome for these patients is poor once bleeding has occurred.

Original languageEnglish
Pages (from-to)764-768
Number of pages5
JournalWorld journal of surgery
Volume18
Issue number5
DOIs
Publication statusPublished - Sep 1 1994

Fingerprint

Sclerotherapy
Esophageal and Gastric Varices
Injections
Hemorrhage

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Ohta, M., Hashizume, M., Kamakura, T., Ueno, K., Tomikawa, M., Tanoue, K., ... Sugimachi, K. (1994). Endoscopic injection sclerotherapy for esophageal varices in the elderly. World journal of surgery, 18(5), 764-768. https://doi.org/10.1007/BF00298925

Endoscopic injection sclerotherapy for esophageal varices in the elderly. / Ohta, Masayuki; Hashizume, Makoto; Kamakura, Tatsuro; Ueno, Kiichiro; Tomikawa, Morimasa; Tanoue, Kazuo; Kitano, Seigo; Sugimachi, Keizo.

In: World journal of surgery, Vol. 18, No. 5, 01.09.1994, p. 764-768.

Research output: Contribution to journalArticle

Ohta, M, Hashizume, M, Kamakura, T, Ueno, K, Tomikawa, M, Tanoue, K, Kitano, S & Sugimachi, K 1994, 'Endoscopic injection sclerotherapy for esophageal varices in the elderly', World journal of surgery, vol. 18, no. 5, pp. 764-768. https://doi.org/10.1007/BF00298925
Ohta M, Hashizume M, Kamakura T, Ueno K, Tomikawa M, Tanoue K et al. Endoscopic injection sclerotherapy for esophageal varices in the elderly. World journal of surgery. 1994 Sep 1;18(5):764-768. https://doi.org/10.1007/BF00298925
Ohta, Masayuki ; Hashizume, Makoto ; Kamakura, Tatsuro ; Ueno, Kiichiro ; Tomikawa, Morimasa ; Tanoue, Kazuo ; Kitano, Seigo ; Sugimachi, Keizo. / Endoscopic injection sclerotherapy for esophageal varices in the elderly. In: World journal of surgery. 1994 ; Vol. 18, No. 5. pp. 764-768.
@article{884972fdb1b2436682dd24e129950dd1,
title = "Endoscopic injection sclerotherapy for esophageal varices in the elderly",
abstract = "A group of 1127 patients who underwent sclerotherapy for esophageal varices were compared for outcome in terms of age: over and ander age 70 years. Esophageal varices were completely eradicated in 81 of 110 patients >70 years (73.6{\%}) and in 791 of 1017 patients <70 years (77.8{\%}). Gastrointestinal bleeding after sclerotherapy occurred in 9 patients >70 years (8.2{\%}) and in 84 of those <70 years (8.3{\%}). Complications occurred in 16 patients >70 years (14.5{\%}) and in 141 <70 years (13.9{\%}). Liver failure and hepatoma accounted for more than 80{\%} of the causes of death in both groups (80.3{\%} versus 83.8{\%}). The 5-year cumulative survival rates in patients with bleeding esophageal varices (bleeders) without hepatoma were 21.8{\%} in those >70 years and 58.7{\%} in those <70 years (p<0.01), the relative survivals being 25.3{\%} versus 66.6{\%}. Patients without hepatoma and treated by prophylactic sclerotherapy accounted for 66.2{\%} of patients >70 years and 61.7{\%} of those <70 years, the relative survivals being 75.9{\%} versus 71.9{\%}. As analyzed by the Cox proportional-hazards model, age >70 years was a prognostic factor in the bleeders (p<0.01) but not in the nonbleeders. We recommend that elderly patients with esophageal varices be given prophylactic sclerotherapy, as the outcome for these patients is poor once bleeding has occurred.",
author = "Masayuki Ohta and Makoto Hashizume and Tatsuro Kamakura and Kiichiro Ueno and Morimasa Tomikawa and Kazuo Tanoue and Seigo Kitano and Keizo Sugimachi",
year = "1994",
month = "9",
day = "1",
doi = "10.1007/BF00298925",
language = "English",
volume = "18",
pages = "764--768",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Endoscopic injection sclerotherapy for esophageal varices in the elderly

AU - Ohta, Masayuki

AU - Hashizume, Makoto

AU - Kamakura, Tatsuro

AU - Ueno, Kiichiro

AU - Tomikawa, Morimasa

AU - Tanoue, Kazuo

AU - Kitano, Seigo

AU - Sugimachi, Keizo

PY - 1994/9/1

Y1 - 1994/9/1

N2 - A group of 1127 patients who underwent sclerotherapy for esophageal varices were compared for outcome in terms of age: over and ander age 70 years. Esophageal varices were completely eradicated in 81 of 110 patients >70 years (73.6%) and in 791 of 1017 patients <70 years (77.8%). Gastrointestinal bleeding after sclerotherapy occurred in 9 patients >70 years (8.2%) and in 84 of those <70 years (8.3%). Complications occurred in 16 patients >70 years (14.5%) and in 141 <70 years (13.9%). Liver failure and hepatoma accounted for more than 80% of the causes of death in both groups (80.3% versus 83.8%). The 5-year cumulative survival rates in patients with bleeding esophageal varices (bleeders) without hepatoma were 21.8% in those >70 years and 58.7% in those <70 years (p<0.01), the relative survivals being 25.3% versus 66.6%. Patients without hepatoma and treated by prophylactic sclerotherapy accounted for 66.2% of patients >70 years and 61.7% of those <70 years, the relative survivals being 75.9% versus 71.9%. As analyzed by the Cox proportional-hazards model, age >70 years was a prognostic factor in the bleeders (p<0.01) but not in the nonbleeders. We recommend that elderly patients with esophageal varices be given prophylactic sclerotherapy, as the outcome for these patients is poor once bleeding has occurred.

AB - A group of 1127 patients who underwent sclerotherapy for esophageal varices were compared for outcome in terms of age: over and ander age 70 years. Esophageal varices were completely eradicated in 81 of 110 patients >70 years (73.6%) and in 791 of 1017 patients <70 years (77.8%). Gastrointestinal bleeding after sclerotherapy occurred in 9 patients >70 years (8.2%) and in 84 of those <70 years (8.3%). Complications occurred in 16 patients >70 years (14.5%) and in 141 <70 years (13.9%). Liver failure and hepatoma accounted for more than 80% of the causes of death in both groups (80.3% versus 83.8%). The 5-year cumulative survival rates in patients with bleeding esophageal varices (bleeders) without hepatoma were 21.8% in those >70 years and 58.7% in those <70 years (p<0.01), the relative survivals being 25.3% versus 66.6%. Patients without hepatoma and treated by prophylactic sclerotherapy accounted for 66.2% of patients >70 years and 61.7% of those <70 years, the relative survivals being 75.9% versus 71.9%. As analyzed by the Cox proportional-hazards model, age >70 years was a prognostic factor in the bleeders (p<0.01) but not in the nonbleeders. We recommend that elderly patients with esophageal varices be given prophylactic sclerotherapy, as the outcome for these patients is poor once bleeding has occurred.

UR - http://www.scopus.com/inward/record.url?scp=0028133372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028133372&partnerID=8YFLogxK

U2 - 10.1007/BF00298925

DO - 10.1007/BF00298925

M3 - Article

C2 - 7975697

AN - SCOPUS:0028133372

VL - 18

SP - 764

EP - 768

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 5

ER -